Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun 13:3:148.
doi: 10.3389/fimmu.2012.00148. eCollection 2012.

Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism?

Affiliations

Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism?

Jerry Y Niederkorn. Front Immunol. .

Abstract

Evidence of immune privilege in the eye was recorded almost 140 years ago, yet interest in immune privilege languished for almost a century. However, the past 35 years have witnessed a plethora of research and a rekindled interest in the mechanisms responsible for immune privilege in the anterior chamber of the eye. This research has demonstrated that multiple anatomical, structural, physiological, and immunoregulatory processes contribute to immune privilege and remind us of the enormous complexity of this phenomenon. It is widely accepted that immune privilege is an adaptation for reducing the risk of immune-mediated inflammation in organs such as the eye and brain whose tissues have a limited capacity to regenerate. Recent findings suggest that immune privilege also occurs in sites where stem cells reside and raise the possibility that immune privilege is also designed to prevent the unwitting elimination of stem cells by immune-mediated inflammation at these sites. Uveal melanoma arises within the eye and as such, benefits from ocular immune privilege. A significant body of research reveals an intriguing parallel between the mechanisms that contribute to immune privilege in the eye and those strategies used by uveal melanoma cells to evade immune elimination once they have disseminated from the eye and establish metastatic foci in the liver. Uveal melanoma metastases seem to have "plagiarized" the blueprints used for ocular immune privilege to create "ad hoc immune privileged sites" in the liver.

Keywords: anterior chamber; eye; immune privilege; stem cells; uveal melanoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Organ systems involved in the induction of ACAID. Removal of the eye, spleen, or thymus within 72 h of injecting antigen into the anterior chamber prevents the induction of ACAID. Chemical sympathectomy prior to injecting antigen into the anterior chamber also abrogates ACAID. BCR, B cell receptor. Reproduced from Niederkorn (2006), with permission from Nature Publishing Group.

Similar articles

Cited by

References

    1. Aluvihare V. R., Kallikourdis M., Betz A. G. (2004). Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5, 266–27110.1038/ni1037 - DOI - PubMed
    1. Aluvihare V. R., Kallikourdis M., Betz A. G. (2005). Tolerance, suppression and the fetal allograft. J. Mol. Med. 83, 88–9610.1007/s00109-004-0608-2 - DOI - PubMed
    1. Apte R. S., Mayhew E., Niederkorn J. Y. (1997). Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors. Invest. Ophthalmol. Vis. Sci. 38, 1277–1282 - PubMed
    1. Apte R. S., Niederkorn J. Y. (1996). Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J. Immunol. 156, 2667–2673 - PubMed
    1. Apte R. S., Sinha D., Mayhew E., Wistow G. J., Niederkorn J. Y. (1998). Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J. Immunol. 160, 5693–5696 - PubMed